FUERST THOMAS RICHARD 4
4 · PHARMATHENE, INC · Filed Dec 5, 2011
Insider Transaction Report
Form 4
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
- Award
Stock Options (right to buy)
2011-12-01+29,545→ 29,545 totalExercise: $1.21Exp: 2021-12-01→ Common Stock (29,545 underlying) - Award
Stock Options (right to buy)
2011-12-01+75,000→ 75,000 totalExercise: $1.21Exp: 2021-12-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The options vest over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On December 1, 2011, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.21 per share.
- [F3]The options vest 100% on the first anniversary of the grant date.